IP Library Granted Patent US 11,129,985
Granted Patent B2
US 11,129,985 · App. 15/770,032 · Granted Sep 28, 2021

Devices, systems, and methods for stimulation therapy

Inventors: Timothy A. Fayram (Gilroy, CA); Alexander Yeh (Los Altos Hills, CA); Gary Shaw (Santa Clara, CA); Randolph Kerry Armstrong (Katy, TX); Milton M. Morris (Houston, TX); Elia Junco (Menlo Park, CA)
Assignee: NEUSPERA MEDICAL, INC.
A61N1/36062A61N1/0551A61N1/36185A61N1/3756A61N1/3787A61N1/37223A61N1/37247A61N1/37252A61N1/37518H02J7/025H02J50/10H02J50/20H02J50/40H02J50/80H02J50/90A61B5/00A61N1/0558A61N1/37229
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,129,985
App. No.
15/770,032
Granted
Sep 28, 2021
Kind
B2
Abstract

Generally discussed herein are systems, devices, and methods for providing a therapy (e.g., stimulation) and/or data signal using an implantable device. Systems, devices and methods for interacting with (e.g., communicating with, receiving power from) an external device are also provided.

Claims (54)

1. A system comprising:

an external power source including first circuitry configured to provide radio frequency (RF) signals to a location in tissue; and

an implantable device configured to receive the RF signals from the external power source, the implantable device including a distal portion and a proximal portion, wherein the implantable device includes second circuitry in a first housing, an antenna in a separate second housing in the proximal portion, and a first electrode on, or at least partially in, the distal portion, and wherein the antenna is electrically coupled to the second circuitry in the first housing and the first housing is situated between the second housing and the first electrode;

wherein the external power source and the implantable device are configured to communicate at least in part using a backscatter signal, and wherein at least one sub-wavelength structure of the external power source is configured to receive the backscatter signal from the implantable device.

2. The system of claim 1 , wherein the implantable device comprises a flexible, biocompatible, elongated member including the distal portion and the proximal portion; and

a plurality of electrodes situated along the distal portion of the elongated member, wherein the plurality of electrodes includes the first electrode;

wherein the second circuitry is hermetically sealed within the first housing and is configured to receive electrical energy from the external power source and to provide electrical energy to the plurality of electrodes.

3. The system of claim 1 , wherein the second housing is attached to the first housing at a proximal end of the first housing that is opposite a distal end of the first housing.

4. The system of claim 1 , wherein the antenna is a primary antenna and the system further comprises a secondary antenna in the second housing, the secondary antenna shaped and positioned to provide a near field coupling with the primary antenna.

5. The system of claim 1 , wherein the implantable device further comprises:

a feedthrough plate between and connected to the first and separate second housings; and

an electrical conductor in a feedthrough of the feedthrough plate, the conductor electrically connected to the second circuitry and the antenna.

6. The system of claim 5 , wherein the external power source further comprises:

a top cover including a thermally conductive material; and

a bottom cover including a thermally insulative material;

wherein the top cover and bottom cover combine to enclose the first circuitry.

7. The system of claim 6 , further comprising:

thermally conductive fins coupled to the top cover;

recesses in a surface of the bottom cover; and

air vents in the surface of the bottom cover, the air vents thermally coupled to the recesses to dissipate heat towards the top cover.

8. The system of claim 1 , wherein the implantable device comprises at least three electrodes, including the first electrode, configured to deliver a therapy to the tissue, and wherein the second circuitry includes a therapy delivery circuit configured to provide a therapy signal via one or more of the at least three electrodes, the therapy signal comprising a series of at least two electrostimulation pulses provided using respective vectors corresponding to different combinations of the at least three electrodes.

9. The system of claim 8 , wherein the therapy delivery circuit is configured to provide the therapy signal with a specified delay interval between each pulse, and wherein the series of pulses is repeated at least twice.

10. The system of claim 1 , wherein the external power source further comprises:

an RF signal generator system configured to provide multiple different sets of RF signals to two or more sub-wavelength structures of the external power source, each set comprising two or more separate signals; and

a transmitter circuit including excitation ports coupled to respective ones of the two or more sub-wavelength structures, the transmitter circuit coupled to the RF signal generator system, and the transmitter circuit configured to transmit the multiple different sets of RF signals at respective different times to the excitation ports, wherein the excitation ports receive respective ones of the separate signals from each set of RF signals, and wherein each of the transmitted sets of RF signals includes a non-negligible magnetic-field component that is substantially parallel to an external surface of the tissue; and

wherein each set of transmitted RF signals is selected to differently manipulate an evanescent field at or near the tissue surface to transmit a power or data signal to respective different target devices implanted in the tissue.

11. The system of claim 1 , further comprising one or more sutures connected to the implantable device at one or more of: (1) a proximal portion of the second housing; (2) a proximal portion of the first housing; and (3) an attachment structure attached to a proximal end of the second housing.

12. The system of claim 1 , further comprising tines extending outward from a longitudinal axis of the implantable device attached to the proximal portion.

13. The system of claim 1 , wherein the second circuitry in the implantable device is configured to provide the backscatter signal using RF signals received from the external power source.

14. The system of claim 1 , wherein the RF signals provided by the external power source comprise a midfield signal.

15. The system of claim 1 , wherein the external power source is configured to use information from the backscatter signal to identify a portion of a power signal received by the implantable device.

16. The system of claim 1 , wherein the backscatter signal comprises information about one or more of a therapy provided by the implantable device and a physiologic characteristic sensed or measured by the implantable device.

17. An implantable device comprising:

a biocompatible, elongated member including a distal portion and a proximal portion;

a plurality of cylindrical electrodes situated along the distal portion of the elongated member;

a cylindrical, hermetic circuitry housing attached to the proximal portion of the elongated member;

therapy signal circuitry hermetically sealed within the circuitry housing, wherein the therapy signal circuitry is configured to provide electrical energy to the plurality of electrodes;

an antenna housing attached to the circuitry housing at a proximal end of the circuitry housing opposite to an end of the circuitry housing attached to the elongated member;

an antenna in the antenna housing; and

backscatter communication circuitry hermetically sealed within the circuitry housing, wherein the backscatter communication circuitry is configured to use a first signal received via the antenna to provide a backscatter signal to a body-external source device, and wherein the body-external source device comprises a sub-wavelength structure configured to receive the backscatter signal.

18. The device of claim 17 , wherein the antenna is a primary antenna and wherein the device further comprises:

a secondary antenna in a housing attached to the antenna housing, the secondary antenna shaped and positioned to provide a near field coupling with the primary antenna.

19. The device of claim 17 , wherein the antenna is a helical antenna.

20. The device of claim 17 , wherein the backscatter communication circuitry is configured to receive the first signal from the body-external source device.

21. The device of claim 20 , wherein the first signal comprises a midfield signal.

22. The device of claim 17 , wherein the backscatter signal comprises information about one or more of a therapy provided by the implantable device and a physiologic characteristic sensed or measured by the implantable device.

23. A system comprising:

an external power source comprising:

transmitter circuitry configured to provide wireless signals to a location in body tissue; and

receiver circuitry and at least one sub-wavelength structure configured to receive a backscatter signal; and

an implantable device comprising:

an antenna at a proximal portion of the implantable device, the antenna configured to receive the wireless signals from the external power source;

backscatter communication circuitry configured to use the wireless signals to provide the backscatter signal to the external power source; and

therapy signal circuitry configured to use the wireless signals to generate or adjust a therapy provided to the body tissue using one or more electrodes, wherein the one or more electrodes are coupled at a distal portion of the implantable device.

Assignments (2)
SECURITY INTEREST Recorded May 18, 2026
From: NEUSPERA MEDICAL INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 075589/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2018
From: FAYRAM, TIMOTHY A; YEH, ALEXANDER; SHAW, GARY; ARMSTRONG, RANDOLPH KERRY; MORRIS, MILTON M; JUNCO, ELIA
To: NEUSPERA MEDICAL INC.
Reel/Frame 047740/0727 →
Continuity (13)
Provisional Application 62397620 · Sep 21, 2016
Provisional Application 62396478 · Sep 16, 2016
Provisional Application 62373569 · Aug 11, 2016
Provisional Application 62367995 · Jul 28, 2016
Provisional Application 62368005 · Jul 28, 2016
Provisional Application 62350674 · Jun 15, 2016
Provisional Application 62350676 · Jun 15, 2016
Provisional Application 62350681 · Jun 15, 2016
Provisional Application 62350684 · Jun 15, 2016
Provisional Application 62291379 · Feb 4, 2016
Provisional Application 62264239 · Dec 7, 2015
Provisional Application 62244495 · Oct 21, 2015
Related Publication 20190022394A1 · Jan 24, 2019